Anmelden/Registrieren
Erscheinungsjahr:
 
Zurück zur geteilten Ansicht
Lloyd R. Kelland

Veröffentlichungen von Lloyd R. Kelland zu Kelland, Lloyd R. ->
weitere Veröffentlichungen von Lloyd R. Kelland:
Book review (1996)
Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and-resistant human ovarian carcinoma cell lines (1992)
In Vitro and In Vivo Antitumor Activity of Benzyl Isothiocyanate: A Natural Product from Tropaeolum majus (1995)
In Vitro and In Vivo Antitumor Activity of Benzyl Isothiocyanate: A Natural Product from Tropaeolum majus (1995)
In Vitro and In Vivo Antitumor Activity of Benzyl Isothiocyanate: A Natural Product from Tropaeolum majus (1995)
Human ovarian-carcinoma cell lines and companion xenografts: a disease-oriented approach to new platinum anticancer drug discovery (1992)
Preclinical pharmacology of 1069C85, a novel tubulin binder (1994)
Selective potentiation of platinum drug cytotoxicity in cisplatin-sensitive and-resistant human ovarian carcinoma cell lines by amphotericin B (1994)
Preclinical pharmacology of 1069C85, a novel tubulin binder (1994)
Selective potentiation of platinum drug cytotoxicity in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines by amphotericin B (1994)
cis-Diamminedichloroplatinum(II)-induced cell death through apoptosis in sensitive and resistant human ovarian carcinoma cell lines (1996)
Antitumour evaluation of dolastatins 10 and 15 and their measurement in plasma by radioimmunoassay (1996)
Synthesis and in Vitro and in Vivo Antitumor Activity of a Series of Trans Platinum Antitumor Complexes (1995)
Copper bis(diphosphine) complexes: radiopharmaceuticals for the detection of multi-drug resistance in tumours by PET (2000)
A phase I and pharmacology study of an oral platinum complex, JM216: dose-dependent pharmacokinetics with single-dose administration (1995)
Veröffentlichungen zu Kelland, Lloyd R.
Zurück zur geteilten Ansicht
Verfasser Titel Jahr absteigend sortierenaufsteigend sortieren
zeige Details
1
Kèlland, Lloyd R. Book review
in: European journal of clinical pharmacology , ISSN 1432-1041, Vol. 49 (4. 1996), p. 333-334
Zugang: zum Volltext
ähnliche Vorschläge
1996
zeige Details
2
Kelland, Lloyd R., Abel, George Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and-resistant human ovarian carcinoma cell lines
in: Cancer chemotherapy and pharmacology , ISSN 1432-0843, Vol. 30 (6. 1992), p. 444-450
Zugang: zum Volltext
ähnliche Vorschläge
1992
zeige Details
3
Pintão, Ana M.. In Vitro and In Vivo Antitumor Activity of Benzyl Isothiocyanate: A Natural Product from Tropaeolum majus
In: Planta medica. - Stuttgart [u.a.] : Thieme Vol. 61, No. 03 (6. 1995), p. 233-236
Zugang: zum Volltext
ähnliche Vorschläge
1995
zeige Details
4
Pintão, Ana M.. In Vitro and In Vivo Antitumor Activity of Benzyl Isothiocyanate: A Natural Product from Tropaeolum majus
In: Planta medica. - Stuttgart [u.a.] : Thieme Vol. 61, No. 03 (6. 1995), p. 233-236
Zugang: zum Volltext
ähnliche Vorschläge
1995
zeige Details
5
Pintão, Ana M.., Pais, M. Salomé S.., ... In Vitro and In Vivo Antitumor Activity of Benzyl Isothiocyanate: A Natural Product from Tropaeolum majus
in: Planta medica. - Stuttgart [u.a.] : Thieme, ISSN 0032-0943, Vol. 61, No. 03 (1995), p. 233-236
Zugang: zum Volltext
ähnliche Vorschläge
1995
zeige Details
6
Kelland, Lloyd R., Jones, Mervyn, ... Human ovarian-carcinoma cell lines and companion xenografts: a disease-oriented approach to new platinum anticancer drug discovery
in: Cancer chemotherapy and pharmacology , ISSN 1432-0843, Vol. 30 (1. 1992), p. 43-50
Zugang: zum Volltext
ähnliche Vorschläge
1992
zeige Details
7
Raynaud, Florence I., Kelland, Lloyd R., ... Preclinical pharmacology of 1069C85, a novel tubulin binder
in: Cancer chemotherapy and pharmacology , ISSN 1432-0843, Vol. 35 (2. 1994), p. 169-173
Zugang: zum Volltext
ähnliche Vorschläge
1994
zeige Details
8
Sharp, Swee Y., Mistry, Prakash, ... Selective potentiation of platinum drug cytotoxicity in cisplatin-sensitive and-resistant human ovarian carcinoma cell lines by amphotericin B
in: Cancer chemotherapy and pharmacology , ISSN 1432-0843, Vol. 35 (2. 1994), p. 137-143
Zugang: zum Volltext
ähnliche Vorschläge
1994
zeige Details
9
Raynaud, F. I., Kelland, Lloyd R., ... Preclinical pharmacology of 1069C85, a novel tubulin binder
in: Cancer chemotherapy and pharmacology , ISSN 1432-0843, Vol. 35 (2. 1994), p. 169-173
Zugang: zum Volltext
ähnliche Vorschläge
1994
zeige Details
10
Sharp, S. Y., Mistry, P., ... Selective potentiation of platinum drug cytotoxicity in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines by amphotericin B
in: Cancer chemotherapy and pharmacology , ISSN 1432-0843, Vol. 35 (2. 1994), p. 137-143
Zugang: zum Volltext
ähnliche Vorschläge
1994
zeige Details
11
Ormerod, Michael G., O’Neill, Ciaran, ... cis-Diamminedichloroplatinum(II)-induced cell death through apoptosis in sensitive and resistant human ovarian carcinoma cell lines
in: Cancer chemotherapy and pharmacology , ISSN 1432-0843, Vol. 37 (5. 1996), p. 463-471
Zugang: zum Volltext
ähnliche Vorschläge
1996
zeige Details
12
Aherne, G. W., Hardcastle, Anthea, ... Antitumour evaluation of dolastatins 10 and 15 and their measurement in plasma by radioimmunoassay
in: Cancer chemotherapy and pharmacology , ISSN 1432-0843, Vol. 38 (3. 1996), p. 225-232
Zugang: zum Volltext
ähnliche Vorschläge
1996
zeige Details
13
Kelland, Lloyd R.., Barnard, F. J.., ... Synthesis and in Vitro and in Vivo Antitumor Activity of a Series of Trans Platinum Antitumor Complexes
In: Journal of medicinal chemistry. - Easton, Pa. : American Chemical Society, ISSN 1520-4804, Vol. 38, No. 16 (1995), p. 3016-3024
Zugang: zum Volltext
ähnliche Vorschläge
1995
zeige Details
14
Lewis, Jason S., Dearling, Jason L. J., ... Copper bis(diphosphine) complexes: radiopharmaceuticals for the detection of multi-drug resistance in tumours by PET
Vol. 27 (6. 2000), p. 638-646
Zugang: zum Volltext
ähnliche Vorschläge
2000
zeige Details
15
McKeage, M. J., Mistry, Prakash, ... A phase I and pharmacology study of an oral platinum complex, JM216: dose-dependent pharmacokinetics with single-dose administration
in: Cancer chemotherapy and pharmacology , ISSN 1432-0843, Vol. 36 (6. 1995), p. 451-458
Zugang: zum Volltext
ähnliche Vorschläge
1995
zeige Details
16
McKeage, Mark J., Mistry, Prakash, ... A phase I and pharmacology study of an oral platinum complex, JM216: dose-dependent pharmacokinetics with single-dose administration
in: Cancer chemotherapy and pharmacology , ISSN 1432-0843, Vol. 36 (6. 1995), p. 451-458
Zugang: zum Volltext
ähnliche Vorschläge
1995